The UK’s Medicines and Healthcare products Regulatory Agency (MHRA)
has launched a formal public consultation on the consolidation of UK
medicines legislation. MHRA’s goal is to simplify existing laws
regulating medicines in the UK, and the agency has invited stakeholders
and the public to provide input. The initiative seeks to replace around
200 legal statutes and much of the Medicines Act of 1968. “It
will amalgamate 40 years of outdated and fragmented legislation,
reducing it by around two thirds, making it clearer and easier to
understand as well as ensuring that medicines regulation is supported by
a modern and straightforward legal framework,” said MHRA Chief
Executive, Sir Kent Woods.
Read more: